헬리코박터 파일로리(H. pylori) 진단 시장 규모, 점유율, 성장 분석 : 검사 유형별, 방법별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 674.75 Million in 2024 and is poised to grow from USD 721.31 Million in 2025 to USD 1230.11 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global diagnostics market for Helicobacter pylori is gaining traction due to its role in enhancing diagnosis, enabling effective treatment, and lowering healthcare expenses. Early detection through advanced diagnostic tests is vital for preventing disease progression and mitigating complications associated with H. pylori infections. Innovative, non-invasive testing methods such as blood, breath, and stool antigen tests make detection accessible and comfortable for patients, while being cost-effective and increasing availability across broader demographics. This diagnostic efficiency allows healthcare providers to initiate timely treatment, yielding improved patient outcomes, symptom relief, and faster healing of ulcers. Additionally, effective treatment options, including antibiotics and acid-reducing medications, play a critical role in thwarting severe complications, thus enhancing patients' overall health and quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter pylori H. pylori Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter pylori H. pylori Diagnostics Market Segments Analysis

Global Helicobacter pylori H. pylori Diagnostics Market is segmented by Test Type, Method, End User and region. Based on Test Type, the market is segmented into Invasive, Histology, Rapid Urease Test, HP Culture, Non-Invasive, Serologic Test, Urea Breath Test and Stool Antigen Test. Based on Method, the market is segmented into Immunoassays, Molecular diagnostics, Point of Care (POC) and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Helicobacter pylori H. pylori Diagnostics Market

The global Helicobacter pylori diagnostics market is driven by the high incidence of H. pylori infections worldwide, with nearly half of the population estimated to be affected by this prevalent bacterial infection. This widespread occurrence has led to an increasing demand for accurate diagnostic tests and effective treatment solutions. As awareness of H. pylori's health implications grows, the need for reliable diagnosis and appropriate management of the infection becomes more critical. Consequently, healthcare providers and patients alike are seeking innovative diagnostics that can lead to timely interventions, underscoring the market's expansion and the urgency for enhanced treatment options.

Restraints in the Global Helicobacter pylori H. pylori Diagnostics Market

The expansion of the global H. pylori diagnostics market faces challenges due to inadequate healthcare resources and diagnostic capabilities in various developing regions. Access to specialized medical equipment and expertise needed for the accurate diagnosis and treatment of H. pylori infections is often scarce, limiting patient access to essential healthcare services. This disparity in availability can significantly hinder market growth, as individuals in these areas may struggle to receive the necessary medical attention, ultimately affecting the overall progress and development of H. pylori diagnostics on a broader scale. Addressing these constraints is crucial for improving healthcare outcomes in affected regions.

Market Trends of the Global Helicobacter pylori H. pylori Diagnostics Market

The Global Helicobacter pylori (H. pylori) diagnostics market is experiencing a significant trend towards increased adoption of non-invasive methods, particularly serology tests and urea breath tests. This shift is largely driven by patient preference for convenient and less invasive procedures, alongside advancements in diagnostic technology that enhance accuracy and reliability. As healthcare providers focus on improving patient experiences and outcomes, the demand for these non-invasive tests is surging, reflecting a broader movement towards accessible and efficient diagnostics. This trend not only facilitates early detection and treatment of H. pylori infections but also signifies a growing awareness of gastrointestinal health among populations worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Helicobacter pylori H. pylori Diagnostics Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Invasive
• Histology
• Rapid Urease Test
• HP Culture
• Non-Invasive
• Serologic Test
• Urea Breath Test
• Stool Antigen Test

Global Helicobacter pylori H. pylori Diagnostics Market Size by Method & CAGR (2026-2033)

• Market Overview
• Immunoassays
• Molecular diagnostics
• Point of Care (POC)
• Others

Global Helicobacter pylori H. pylori Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Diagnostic Labs
• Others

Global Helicobacter pylori H. pylori Diagnostics Market Size & CAGR (2026-2033)

• North America (Test Type, Method, End User)
  • US
  • Canada
• Europe (Test Type, Method, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Method, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Method, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Method, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epitope Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biohit Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations